Arnold & Porter

Arnold & Porter's IP team specializes in general patent litigation, Hatch-Waxman disputes and patent strategy for clients across technology areas. Major IP clients of the firm include Boston Scientific, Hologic, Sanofi and Bayer.

IP group co-chair Matthew Wolf was involved in high-profile litigations for a number of major life sciences clients, including Boston Scientific in a global patent dispute against Edwards Lifesciences. The matter settled in early 2019, resulting in a $180 million payment to Boston Scientific. Wolf was awarded General Patent Litigator of the Year in Washington, DC by LMG Life Sciences for his active year in the space.

Litigation partner David Barr specializes in Hatch-Waxman and biotechnology disputes. Barr, Wolf and Silicon Valley partner Deborah Fishman were involved in the closely watched antibody dispute Amgen v Sanofi, which recently concluded at retrial. Daniel DiNapoli and Aaron Stiefel are acting for Pfizer in Hatch-Waxman litigations defending against generic challenges to the client's Xeljanz and Bosulifproducts.

For patent strategy, David Marsh is recommended for his expertise managing life sciences patent portfolios. He is currently active for Bayer and Bruin Biometrics in prosecution and strategy.

Arnold & Porter maintains a substantial presence in the life sciences industry, with a practice that encompasses all legal areas needed to support a product's life cycle. The firm ranks highest in pricing and reimbursement and antitrust litigation, but is also a significant player in patent litigation, patent strategy, M&A and FDA counseling. The firm offers roughly 200 attorneys dedicated to the industry area, nearly half of whom hold scientific degrees.

The firm's regulatory practice is one of the premier groups focused on pharmaceutical and medical device clients. One client highlights the firm "does excellent work, is client-focused, and realistic." A peer adds, "They have some of the best pricing litigators in the country." Life sciences practice co-chair Dan Kracov supports the firm's reputation for regulatory work, with one client labeling him "the highest caliber." Jeff Handwerker is well-regarded for his work advising a number of life sciences companies in all aspects of their product development, with a particular expertise assisting pharmaceutical and medical device clients. LMG Life Sciences newcomer Mahnu Davar regularly works with Kracov assisting clients on a host of FDA-related regulatory and compliance matters.

In IP, group co-chair Matthew Wolf was awarded General Patent Litigator of the Year in Washington, DC for an active year in high-profile disputes. Among his notable representations was a case for Boston Scientific against Edwards Lifesciences, which recently settled, ending the global dispute between the two companies. David Barr and Deborah Fishman also acted alongside Wolf in the closely watched antibody dispute Amgen v Sanofi, which involves how broadly antibodies can be covered by patents. Daniel DiNapoli and Aaron Stiefel are currently acting for Pfizer in Hatch-Waxman litigations challenging two of the client's products, Xeljanz and Bosulif.

The firm's high-caliber antitrust group includes senior partner Laura Shores, who brings more than 25 years of experience in litigation. She recently acted for Novartis in multiple matters, one involving "pay for delay" allegations brought by pharmaceutical company Miami-Luken. The 2019 Government Investigations Attorney of the Year award went to DC-based Kirk Ogrosky, who is currently defending UCB in a qui tam matter involving the Anti-Kickback Statute and False Claims Act. For product liability matters, William Hoffman is labeled "one of the best practitioners in this field of law" by a peer.

Derek Stoldt serves as co-head of the firm's M&A and life sciences transactions practice groups from the New York office. He and Aaron Gardner recently advised Novartis in its sale of cystic fibrosis products to Mylan, valued at $463 million. Julia Vax is a standout in the firm's corporate practice, who regularly represents medical device, diagnostics and biopharmaceutical companies. Past representations include Bayer in the sale of commercial rights to a compound.

Arnold & Porter is a full-service life sciences firm with top-tier status in antitrust matters, and additional national rankings in product liability and white-collar defense. A peer notes the firm has "solid credentials" in life sciences-related litigation. For the firm's involvement in high-profile competition suits, Arnold & Porter was awarded 2019 Antitrust Firm of the Year by LMG Life Sciences.

The firm's high-caliber antitrust group includes senior partner Laura Shores, who brings more than 25 years of experience in litigation. She recently acted for Novartis in multiple matters, one involving "pay for delay" allegations brought by pharmaceutical company Miami-Luken. Saul Morgenstern worked alongside Shores in a Novartis matter against United Food and Commercial Workers Unions involving the client's Gleevec product.

The 2019 Government Investigations Attorney of the Year award went to DC-based Kirk Ogrosky, who is currently defending UCB in a qui tam matter involving the Anti-Kickback Statute and False Claims Act. Ogrosky and New York partner Anand Agneshwar are also representing Bristol-Myers Squibb and Sanofi in government investigations related to promotion of the drug Plavix.

For product liability matters, William Hoffman is labeled "one of the best practitioners in this field of law" by a peer. Hoffman is currently active for Pfizer in a series of cases alleging cerebellar atrophy arose from use of the company's Dilantin drug. Los Angeles partner Pamela Yates is "fantastic" and "very talented" to peers for her practice focused on class actions and product liability suits. She is noteworthy for her high-profile representations in the life sciences area, exemplified by her recent defense of Bayer in a series of national mass torts involving the company's Xarelto product. Yates is currently co-chair of the firm's product liability practice group. Lori Leskin and Andrew Solow also represented Bayer in separate actions involving antibiotic drugs Cipro and Avelox.

Headquartered in DC, Arnold & Porter is a full-service firm with an established reputation for assisting life science clients in an array of regulatory matters. In addition to handling all issues for pharmaceutical and medical device companies in front of the FDA, the firm also has experienced professionals in the pricing and reimbursement space. One client highlights the firm "does excellent work, is client-focused, and realistic." A peer adds, "they have some of the best pricing litigators in the country."

Life sciences practice co-chair Dan Kracov is routinely recognized as a top regulatory attorney, with one client labeling him "the highest caliber." Kracov represents both major and emerging companies in the pharmaceutical, biotechnology, medical device and diagnostics space throughout the entire life cycle including development, approval, and marketing issues with the FDA.

Jeff Handwerker is well-regarded for his work advising a number of life sciences companies in all aspects of their product development, with a particular expertise assisting pharmaceutical and medical device clients.

A new addition to this year's stars list is Mahnu Davar, who regularly works with Kracov assisting clients on a host of FDA-related regulatory and compliance matters.